Market Place
Sourcing Support
Alembic Pharma Gets USFDA Nod For Dapagliflozin Tablets
07 Apr 2026 //
EXPRESSPHARMA
Alembic Gets USFDA Nod For Paroxetine ER Tablets
28 Mar 2026 //
INDPHARMAPOST
Alembic receives USFDA approval for Lamotrigine Orally tablets
27 Feb 2026 //
EXPRESS PHARMA
Alembic Pharma Gets FDA Nod for Generic Antifungal Solution
24 Feb 2026 //
ECONOMICTIMES
Alembic Pharma Receives USFDA Approval For Generic Parkinson`s
06 Feb 2026 //
ECONOMICTIMES
Alembic Gets USFDA Nod For Difluprednate Ophthalmic Emulsion
27 Jan 2026 //
EXPRESSPHARMA
Alembic Announces USFDA Tentative Approval For Bosutinib Tablets
12 Jan 2026 //
INDPHARMAPOST
FDA Approves Alembic`s Travoprost Ophthalmic Solution USP
22 Dec 2025 //
INDPHARMAPOST
USFDA Approves Alembic`s 0.004% Travoprost Solution
18 Dec 2025 //
EXPRESSPHARMA
FDA Approves Alembic`s Loteprednol-Tobramycin Eye Drops
11 Dec 2025 //
EXPRESSPHARMA
Alembic Gets USFDA Nod For Dexlansoprazole Delayed-Release
13 Nov 2025 //
EXPRESSPHARMA
Alembic Gets FDA Final Nod For Sumatriptan Injection USP
09 Nov 2025 //
INDPHARMAPOST
Alembic Announces USFDA Final Approval For Dasatinib Tablets
08 Nov 2025 //
INDPHARMAPOST
Alembic Pharma Gets USFDA Nod For 60mg Ticagrelor Tablets
29 Oct 2025 //
EXPRESSPHARMA
FDA Approves Alembic`s Triamcinolone Acetonide Injectable
19 Oct 2025 //
INDPHARMAPOST
Alembic Pharma Receives USFDA Approval For Generic Depression
25 Sep 2025 //
ECONOMICTIMES
Alembic Receives FDA Final Approval for Phytonadione Injectable
10 Sep 2025 //
INDPHARMAPOST
Alembic Gets USFDA Approval for 10mg Macitentan Tablets
19 Aug 2025 //
INDPHARMAPOST
Alembic Gets USFDA Nod for Generic Drug for Skin Condition
18 Aug 2025 //
ECONOMICTIMES
Alembic Pharma Gets USFDA Approval for Carbamazepine Tablets
28 Jul 2025 //
EXPRESSPHARMA
Alembic Pharma Gets Final FDA Nod for Carbamazepine ER Tablets
27 Jul 2025 //
INDPHARMAPOST
Alembic Gets US FDA Approval for Doxorubicin Liposome
30 Jun 2025 //
EXPRESSPHARMA
Alembic Announces USFDA Final Approval for Single-Dose Vials
29 Jun 2025 //
INDPHARMAPOST
Alembic Gets USFDA Final Approval for Amlodipine & Atorvastatin
23 May 2025 //
EXPRESSPHARMA
Alembic Pharmaceuticals gets USFDA approval for Rivaroxaban Table
18 May 2025 //
INDPHARMAPOST
Alembic gets USFDA final approval for Ticagrelor Tablets
05 May 2025 //
INDPHARMAPOST
Alembic gets USFDA approval for Carbamazepine Tablets
18 Apr 2025 //
INDPHARMAPOST
Alembic announces FDA final approval for Pantoprazole for Inj
05 Apr 2025 //
INDPHARMAPOST
Alembic Pharma Gets USFDA Approval For Brexpiprazole Tablets
15 Jan 2025 //
EXPRESSPHARMA
Alembic Pharma gets USFDA nod for seizure treatment drug
20 Dec 2024 //
BUSINESS STD
Alembic Pharma gets tentative USFDA nod for Olopatadine drug
04 Dec 2024 //
BUSINESS STD
Alembic Pharma Gains USFDA Approval for Ivabradine Tablets
12 Nov 2024 //
EXPRESSPHARMA
Alembic Pharma gets FDA nod for Diltiazem HCl ER capsules
11 Nov 2024 //
BUSINESS STD
Alembic Pharma gets FDA nod for generic hypertension capsules
21 Oct 2024 //
ECONOMICTIMES
Alembic gains FDA approval for Lamotrigine Extended-Release Tablets
04 Oct 2024 //
EXPRESSPHARMA
Alembic Gains USFDA Approval For Lamotrigine Extended-Release
03 Oct 2024 //
EXPRESSPHARMA
Alembic Pharma gets USFDA nod for schizophrenia Drug
28 Sep 2024 //
ECONOMICTIMES
Alembic Pharma gets USFDA nod for generic drug
26 Aug 2024 //
ECONOMICTIMES
Alembic gets USFDA nod for generic medication
13 Aug 2024 //
ECONOMICTIMES
Alembic Gets USFDA Tentative Approval For Selexipag Injection
14 Jul 2024 //
INDIANPHARMAPOST
Alembic Pharma Gets USFDA Nod for Generic Hereditary Angioedema Injection
17 Jun 2024 //
ECONOMICTIMES
Alembic Pharma plans to launch 25 drugs in US generics segment this fiscal
16 May 2024 //
ECONOMICTIMES
Alembic intros generic Aubagio
22 Mar 2023 //
DRUGSTORENEWS
Alembic Pharma gets USFDA nod to market generic antidepressant drug
09 Mar 2023 //
ECONOMIC TIMES
Alembic Pharma gets USFDA nod to market generic cancer drug
01 Mar 2023 //
ECONOMIC TIMES
Alembic Pharma gets USFDA nod for generic drug to treat breast cancer
26 Dec 2022 //
ECONOMICTIMES
Novartis files another Entresto patent suit to fight generics
27 Oct 2022 //
FIERCEPHARMA
FDA greenlights nine Lyrica generics
25 Jul 2019 //
IN-PHARMATECHNOLOGIST
Alembic Pharma gets USFDA nod for neuropathic pain management drug
22 Jul 2019 //
BUSINESS STANDARD
Lamictal XR (lamotrigine): Alembic Pharmaceuticals vs. GlaxoSmithKline
02 Oct 2018 //
PATENT LITIGATION
Adempas® (Riociguat ): Adverio Pharma Gmbh V. Alembic Pharmaceuticals
09 Jan 2018 //
PATENT LITIGATION
Fire disrupts production at Alembic generics plant in Algeria
23 Aug 2017 //
FIERCE PHARMA
Alembic Pharma launches oncology site for injectable and lyophilized generics
18 Jul 2017 //
IN PHARMATECHNOLOGIST
USFDA promises faster approvals, Aadhaar must for TB treatment
23 Jun 2017 //
MONEYCONTROL
